WASHINGTON — Today, the public got a disturbing window into the actions of former Turing Pharmaceuticals CEO Martin Shkreli, a sniggering, contemptuous former hedge fund manager who led a scheme to turn a profit off of price hikes on a crucial life-saving drug. At a House Oversight and Government Reform Committee hearing this morning, Shkreli…
Today the House Oversight Committee released a series of astonishing internal documents revealing the greed behind former Turing Pharmaceuticals CEO Martin Shkreli’s decision to increase by 5,000 percent the cost of the life-saving drug Daraprim. Daraprim is a crucial treatment for many pregnant women and people living with HIV. Last fall, then-Turing CEO Martin Shkreli…
WASHINGTON — Following the news that Martin Shkreli has resigned as CEO of Turing Pharmaceuticals, the Human Rights Campaign (HRC), called on the drug maker’s interim CEO Ron Tilles to immediately reduce the cost of the life-saving drug Daraprim to its original price. “We hope that Martin Shkreli’s departure will mark the end of Turing…
Martin Shkreli, the CEO of Turing Pharmaeauticals, who infamously raised the price of a drug used to treat an infection particularly hazardous for people with HIV was arrested today on charges of securities fraud, reports Bloomberg Business. According to prosecutors, Shkreli’s arrest today is unconnected to the price hike of Daraprim which he raised from $13.50 to…
With his latest interview, Turing Pharmaceuticals CEO Martin Shkreli has officially cemented his place as the worst person in the world and poster child for pharmaceutical greed. Speaking at the Forbes Healthcare Summit during a 25-minute interview Shkreli said, “ I would have raised prices higher,” after being asked how he would re-do the past…
Express Scripts announced Tuesday that it will partner with Imprimis Pharmaceuticals to offer a low-cost alternative to Daraprim, a lifesaving treatment for people living with HIV. Two months ago, Turing Pharmaceuticals’ CEO Martin Shkreli bought the rights to Daraprim and hiked the price of this crucial drug by 5,000 percent overnight. Express Scripts, a major…
Turing Pharmaceuticals, which sparked fury two months ago by increasing the price of the drug Daraprim, said Tuesday that it would not reduce the list price of that drug after all, reports The New York Times. Daraprim is a preferred treatment for toxoplasmosis, a rare parasitic infection that affects people with weak immune systems including…
